Efficacy and Safety of Tadalafil for Erectile Dysfunction in Patients with Multiple Sclerosis

Journal of Sexual Medicine

Volumn 8, Issue 4, 2011, Pages 1257-1258

  Zhang, Hong Liang ^a,b   Pan, Wei ^c   Wu, Jiang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL;

DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 79953314026     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01919.x     Document Type: Letter

References (4)

1. Lombardi G, Macchiarella A, Del Popolo G. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J Sex Med 2010;7:2192-200.
2. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ 2000;321:499-503.
3. Caskurlu T, Tasci AI, Resim S, Sahinkanat T, Ergenekon E. The etiology of erectile dysfunction and contributing factors in different age groups in Turkey. Int J Urol 2004;11:525-9.
4. Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: A double-blind, placebo controlled, randomized study. J Urol 2009;181:252-8.